Augmented Reality Navigation System (Endosight) for the Guidance of Bone Biopsy
Primary Purpose
Bone Lesion, Bone Tumor, Bone Infection
Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
8 Patients who were prescribed a CT-guided percutaneous bone biopsy, performed with the aid of endosight navigation system
Sponsored by
About this trial
This is an interventional diagnostic trial for Bone Lesion
Eligibility Criteria
Inclusion Criteria: Patient with a bone lesion for which a percutaneous biopsy is indicated; Informed consent signed by the patient for participation in the study. Exclusion Criteria: Age < 18 years; Pregnant and lactating women (assessed through auto declaration of the patient)
Sites / Locations
- IRCCS Ospedale Galeazzi - Sant'Ambrogio
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
prospective
retrospective
Arm Description
8 Patients who were prescribed a CT-guided percutaneous bone biopsy, performed with the aid of endosight navigation system
8 Patients with a bone lesion for which a percutaneous biopsy has been performed from January 2011 to May 2022
Outcomes
Primary Outcome Measures
Procedure time
Change in the total duration of the procedure (calculated from the time of local anesthesia injection to the time of bone sample collection)
Total number of CT-SCAN
Change in overall number of CT scans performed during the procedure (calculated as the total number of CT scans required to reach the target; from the 1° CT-scan (local anesthesia) to the last CT-scan (sample collection from the bone)
Secondary Outcome Measures
endosight accuracy
Distance between the tip of the needle and the center of the target (from 0mm to 10mm)
Total radiation dose
Change in the total radiant dose received by the patient (calculated by summing the radiation emitted for each CT-Scan performed from the anesthesia-point to the collection-point)
Operator satisfaction
satisfaction level of the operator (from 0 to 5 - 1: poor satisfaction, 5: high satisfaction)
Side effects
Total number of major+minor side effects, reported during the procedure
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05732558
Brief Title
Augmented Reality Navigation System (Endosight) for the Guidance of Bone Biopsy
Official Title
Assessment of Operative Time, Precision, and Safety of an Augmented Reality Navigation System (Endosight) for the Guidance of Bone Biopsy
Study Type
Interventional
2. Study Status
Record Verification Date
March 2023
Overall Recruitment Status
Completed
Study Start Date
December 16, 2022 (Actual)
Primary Completion Date
March 8, 2023 (Actual)
Study Completion Date
March 8, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
R.A.W. - S.R.L.
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The goal of this clinical study is to evaluate the duration of the procedure, the precision (distance between the needle tip and the centre of the target), and the safety of endosight system in the guidance for bone biopsies.
Detailed Description
In this study results obtained in the prospective group will be compared with those obtained in the retrospective group.
Total N° of patients: 16
PROSPECTIVE GROUP (treated WITH the guidance of endosight):
N° of patients: 8
RETROSPECTIVE GROUP (treated WITHOUT the guidance of endosight):
N° of patients: 8
Main objective of the study:
Reduction of execution times by at least 10 minutes; Reduction of the number of CT scans by at least 2 scans.
N°of hospitals involved: 2.
Duration: maximum 6 months from the date of the first enrollment.
No follow-up is expected.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bone Lesion, Bone Tumor, Bone Infection
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The study is designed to compare a prospective arm composed of 8 patients who were prescribed a CT-Guided bone biopsy (with the aid of endosight navigation system) with a retrospective arm with a bone lesion for which a percutaneous biopsy has been performed from January 2011 to May 2022 (without endosight navigation system)
Masking
Outcomes Assessor
Masking Description
all sensitive data regarding enrolled patients will be transmitted to the Outcomes Assessor anonymously (code assigned to the patient)
Allocation
Non-Randomized
Enrollment
16 (Actual)
8. Arms, Groups, and Interventions
Arm Title
prospective
Arm Type
Experimental
Arm Description
8 Patients who were prescribed a CT-guided percutaneous bone biopsy, performed with the aid of endosight navigation system
Arm Title
retrospective
Arm Type
No Intervention
Arm Description
8 Patients with a bone lesion for which a percutaneous biopsy has been performed from January 2011 to May 2022
Intervention Type
Procedure
Intervention Name(s)
8 Patients who were prescribed a CT-guided percutaneous bone biopsy, performed with the aid of endosight navigation system
Other Intervention Name(s)
augmented reality, endosight, Bone biopsy, Bone tumor, Bone Lesion
Intervention Description
The study is based on a comparison of the number of CT scans required for needle placement in bone biopsies (trunk area) performed with augmented reality navigation system (endosight) and without.
Primary Outcome Measure Information:
Title
Procedure time
Description
Change in the total duration of the procedure (calculated from the time of local anesthesia injection to the time of bone sample collection)
Time Frame
During bone biopsy procedure (after the bone sample has been collected)
Title
Total number of CT-SCAN
Description
Change in overall number of CT scans performed during the procedure (calculated as the total number of CT scans required to reach the target; from the 1° CT-scan (local anesthesia) to the last CT-scan (sample collection from the bone)
Time Frame
During bone biopsy procedure (after the bone sample has been collected)
Secondary Outcome Measure Information:
Title
endosight accuracy
Description
Distance between the tip of the needle and the center of the target (from 0mm to 10mm)
Time Frame
During bone biopsy procedure (after the bone sample has been collected)
Title
Total radiation dose
Description
Change in the total radiant dose received by the patient (calculated by summing the radiation emitted for each CT-Scan performed from the anesthesia-point to the collection-point)
Time Frame
During bone biopsy procedure (after the bone sample has been collected)
Title
Operator satisfaction
Description
satisfaction level of the operator (from 0 to 5 - 1: poor satisfaction, 5: high satisfaction)
Time Frame
During bone biopsy procedure (after the bone sample has been collected)
Title
Side effects
Description
Total number of major+minor side effects, reported during the procedure
Time Frame
During bone biopsy procedure (after the bone sample has been collected)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient with a bone lesion for which a percutaneous biopsy is indicated;
Informed consent signed by the patient for participation in the study.
Exclusion Criteria:
Age < 18 years;
Pregnant and lactating women (assessed through auto declaration of the patient)
Facility Information:
Facility Name
IRCCS Ospedale Galeazzi - Sant'Ambrogio
City
Milano
State/Province
MI
ZIP/Postal Code
20157
Country
Italy
12. IPD Sharing Statement
Learn more about this trial
Augmented Reality Navigation System (Endosight) for the Guidance of Bone Biopsy
We'll reach out to this number within 24 hrs